Ra-Capital-Management-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
85
Total Value
5952606666
Accession Number
0001104659-25-049549
Form Type
13F-HR
Manager Name
Ra-Capital-Management-Lp
Data Enrichment
91% identified
77 identified8 unidentified

Holdings

85 positions • $6.0B total value
Manager:
Search and click to pin securities to the top
SERA PROGNOSTICS, INC.
Shares:3.0M
Value:$11.2M
% of Portfolio:0.2% ($11.2M/$6.0B)
MBX Biosciences, Inc.
Shares:1.5M
Value:$11.2M
% of Portfolio:0.2% ($11.2M/$6.0B)
BICYCLE THERAPEUTICS PLC
Shares:1.1M
Value:$9.3M
% of Portfolio:0.2% ($9.3M/$6.0B)
Arcus Biosciences, Inc.
Shares:1.1M
Value:$8.9M
% of Portfolio:0.1% ($8.9M/$6.0B)
Surrozen, Inc./DE
Shares:679.1K
Value:$7.9M
% of Portfolio:0.1% ($7.9M/$6.0B)
Immatics N.V.
Shares:1.8M
Value:$7.9M
% of Portfolio:0.1% ($7.9M/$6.0B)
Avalo Therapeutics, Inc.
Shares:967.0K
Value:$7.7M
% of Portfolio:0.1% ($7.7M/$6.0B)
G70077105
Shares:750.0K
Value:$7.7M
% of Portfolio:0.1% ($7.7M/$6.0B)
10919W405
Shares:206.4K
Value:$7.4M
% of Portfolio:0.1% ($7.4M/$6.0B)
Aclaris Therapeutics, Inc.
Shares:4.7M
Value:$7.1M
% of Portfolio:0.1% ($7.1M/$6.0B)
Acadia Healthcare Company, Inc.
Shares:217.0K
Value:$6.6M
% of Portfolio:0.1% ($6.6M/$6.0B)
08659B102
Shares:500.0K
Value:$6.1M
% of Portfolio:0.1% ($6.1M/$6.0B)
Xencor Inc
Shares:575.0K
Value:$6.1M
% of Portfolio:0.1% ($6.1M/$6.0B)
Werewolf Therapeutics, Inc.
Shares:6.1M
Value:$6.0M
% of Portfolio:0.1% ($6.0M/$6.0B)
Adicet Bio, Inc.
Shares:7.5M
Value:$5.7M
% of Portfolio:0.1% ($5.7M/$6.0B)
Humacyte, Inc.
Shares:3.3M
Value:$5.6M
% of Portfolio:0.1% ($5.6M/$6.0B)
Zura Bio Ltd
Shares:3.2M
Value:$4.2M
% of Portfolio:0.1% ($4.2M/$6.0B)
BioAge Labs, Inc.
Shares:1.1M
Value:$4.0M
% of Portfolio:0.1% ($4.0M/$6.0B)
Boundless Bio, Inc.
Shares:2.2M
Value:$3.3M
% of Portfolio:0.1% ($3.3M/$6.0B)
28658R106
Shares:2.5M
Value:$3.0M
% of Portfolio:0.1% ($3.0M/$6.0B)